Journal of Human Reproductive Science
Home Ahead of Print Current Issue Archives
   Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size    Users online: 543


 
   Table of Contents     
EDITORIAL  
Year : 2022  |  Volume : 15  |  Issue : 2  |  Page : 101
 

Editorial commentary


Editor-in-Chief, JHRS; Department of Reproductive Medicine, Shreyas Hospital and Sushrut Assisted Conception Clinic, Kolhapur, Maharashtra, India

Date of Submission21-Jun-2022
Date of Decision21-Jun-2022
Date of Acceptance21-Jun-2022
Date of Web Publication30-Jun-2022

Correspondence Address:
Padma Rekha Jirge
Department of Reproductive Medicine, Shreyas Hospital and Sushrut Assisted Conception Clinic, Kolhapur, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jhrs.jhrs_81_22

Rights and Permissions

 



How to cite this article:
Jirge PR. Editorial commentary. J Hum Reprod Sci 2022;15:101

How to cite this URL:
Jirge PR. Editorial commentary. J Hum Reprod Sci [serial online] 2022 [cited 2022 Nov 26];15:101. Available from: https://www.jhrsonline.org/text.asp?2022/15/2/101/349557




A warm welcome to the April – June 2022 issue of the JHRS! This issue comes with two reviews, eleven original articles encompassing basic science to clinical aspects of reproduction and two case reports. Okafor et al. provide a comprehensive review of the role of different regions of brain in human reproduction. The second review article of the issue is an overview of the different aspects of ovarian stimulation with an added Indian perspective.

A study by Ghagane et al. in Swiss albino mice explores the therapeutic effects of aloe vera as an adjuvant therapy for polycystic ovarian syndrome (PCOS). A study by Rafaee et al. reports the effect of a particular lubricant on the sperm parameters both in-vitro and in-vivo. Patel et al. have addressed the role of a second ejaculate in men with severe oligoasthenoteratospermia, on embryo parameters following intracytoplasmic sperm injection (ICSI). They report an increase in the number of good quality embryos. However, retrospective nature of the study and lack of pregnancy outcomes remain the limitations of the study. A prospective study by Srinivas et al. compares the pregnancy rate following sperm preparation using microfluidics and density gradient techniques in a oocyte donation program and reports no difference between the two methods of sperm preparation.

Banker et al. report the clinical and embryological outcomes of in-vitro fertilisation (IVF) performed during the first wave of COVID-19 pandemic in India. The study documents safe practice of IVF by adhering to national and international safety guidelines. A retrospective analysis by Nadkarni Singh et al. reports the role of preimplantation genetic testing in a selected group of women with poor prognosis undergoing ICSI. A retrospective cohort study by Coussa et al. explores the maternal thyroid stimulating hormone (TSH) values and pregnancy outcomes of IVF conceptions.

Nayak et al. in a retrospective study report the beneficial role of yoga, meditation and counselling integrated into aetiology based treatment of infertility. A cross-sectional pilot study by Patel et al. reports on the clinical validity of the fertility problem inventory in an Indian population.

Ghadirkhomi et al. have reported on the underlying genetic issues in girls with primary amenorrhoea highlighting the need for genetic counselling and testing in this young population. Talwar et al. in a case-control study report on the association of specific genetic polymorphisms and recurrent pregnancy loss. The two case reports address the challenges of empty follicles during oocyte retrieval and fertility preservation for oncological and non-oncological conditions.

It is mandatory that any research involving human participants is conducted within the regulatory norms of the country. In India, it translates to adherence to the Drugs and Cosmetics Act (1940), Rules (1945) and amendments including Schedule Y and the New Drugs and Clinical Trials Rules, 2019. In addition, the researchers should be compliant with the Declaration of Helsinki (2013 version) which is the policy statement of the World Medical Association. It is important to be cognisant of the editorial and publisher's statements on ethics while submitting any manuscript for consideration of publication in a biomedical journal.

Best Wishes,






 

Top
Print this article  Email this article
             

    

 
   Search
 
  
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Article in PDF (384 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  



 Article Access Statistics
    Viewed3565    
    Printed90    
    Emailed0    
    PDF Downloaded542    
    Comments [Add]    

Recommend this journal